Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

Filgrastim 13Peripheral Blood Stem Cell Transplantation 10Melphalan 9Ifosfamide 9Etoposide 9Cyclophosphamide 8Thiotepa 6Carboplatin 6Busulfan 6Radiotherapy 5Doxorubicin 5Vincristine 3Topotecan 3Temozolomide 3Docetaxel 3trioctyl phosphine oxide 2temsirolimus 2etoposide phosphate 2Transplantation 2Surgical Procedures, Operative 2Stem Cell Transplantation 2Radiotherapy, Intensity-Modulated 2Microarray Analysis 2Mesna 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Dexrazoxane 2Cisplatin 2Bone Marrow Transplantation 2Amifostine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive, Peripheral × indolepropanol phosphate × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡